What is NDC 13107-036?

13107-036 is the product NDC for Dextroamphetamine Sulfate, Dextroamphetamine sulfate 10 mg/1 tablet, listed with the FDA by Aurolife Pharma, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Aurolife Pharma, LLC, NDC labeler code 13107. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dextroamphetamine Sulfate?

38 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dextroamphetamine Sulfate NDC 13107-036

NDC codes

FDA NDC Directory

Product NDC (as listed)13107-036Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13107-0036Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
13107-036-01	1310700360113107003601	100 TABLET in 1 BOTTLE (13107-036-01)Marketed from Jul 31, 2013
13107-036-50	1310700365013107003650	50 TABLET in 1 BOTTLE (13107-036-50)Marketed from Jul 31, 2013
13107-036-99	1310700369913107003699	1000 TABLET in 1 BOTTLE (13107-036-99)Marketed from Jul 31, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dextroamphetamine Sulfate
Generic name (nonproprietary): dextroamphetamine sulfate
Active ingredients: Dextroamphetamine sulfate — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aurolife Pharma, LLCNDC labeler code 13107
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202893
Marketing start: Jul 31, 2013
Listing expires: Dec 31, 2027
DEA schedule: CII
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)
Identifiers: Product ID 13107-036_9f989dfd-e290-448a-a66f-b22eaf61c9fdSPL ID 9f989dfd-e290-448a-a66f-b22eaf61c9fdSPL set ID 24163442-dd03-4066-a6ed-eb7e292b700bRxCUI 884385, 884386UNII JJ768O327N
Pharmacologic class: Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413107003601 followed by a unit qualifier and the quantity

Package 13107-0036-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 21, 2026. This label includes a boxed warning.

Full label on DailyMed (opens in a new tab)

About NDC 13107-036

What is NDC 13107-036?: 13107-036 is the product NDC for Dextroamphetamine Sulfate, Dextroamphetamine sulfate 10 mg/1 tablet, listed with the FDA by Aurolife Pharma, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dextroamphetamine Sulfate.
What is the active ingredient?: Dextroamphetamine sulfate.
Who is the labeler?: Aurolife Pharma, LLC, NDC labeler code 13107. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dextroamphetamine Sulfate?: 38 other product NDCs are listed under this name. See all Dextroamphetamine Sulfate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dextroamphetamine Sulfate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 5 mg/1	TabletOral	Cranbury Pharmaceuticals, LLC	27808-089	27808-0089-01
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 10 mg/1	TabletOral	Cranbury Pharmaceuticals, LLC	27808-090	27808-0090-01
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 2.5 mg/1	TabletOral	Winder Laboratories LLC	75826-120	75826-0120-1075826-0120-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 5 mg/1	TabletOral	Winder Laboratories LLC	75826-121	75826-0121-1075826-0121-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 7.5 mg/1	TabletOral	Winder Laboratories LLC	75826-122	75826-0122-1075826-0122-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 10 mg/1	TabletOral	Winder Laboratories LLC	75826-123	75826-0123-1075826-0123-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 15 mg/1	TabletOral	Winder Laboratories LLC	75826-124	75826-0124-1075826-0124-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 20 mg/1	TabletOral	Winder Laboratories LLC	75826-125	75826-0125-1075826-0125-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 30 mg/1	TabletOral	Winder Laboratories LLC	75826-126	75826-0126-1075826-0126-30
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 15 mg/1	TabletOral	Wilshire Pharmaceuticals, Inc.	52536-515	52536-0515-03

All 39 Dextroamphetamine Sulfate NDCs

Other NDCs under ANDA 202893

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202893
Product	Strength	Form · route	Labeler	Product NDC
Dextroamphetamine Sulfate	Dextroamphetamine sulfate 5 mg/1	TabletOral	Aurolife Pharma, LLC	13107-035